Search Results - "KOZUKI, T"

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer by Harada, D., Hata, A., Okuda, C., Kaji, R., Masuda, Y., Takechi, Y., Kozuki, T., Nogami, N., Katakami, N.

Get full text

Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer by Hotta, K., Hida, T., Nokihara, H., Morise, M., Kim, Y.H., Azuma, K., Seto, T., Takiguchi, Y., Nishio, M., Yoshioka, H., Kumagai, T., Watanabe, S., Goto, K., Satouchi, M., Kozuki, T., Shukuya, T., Nakagawa, K., Mitsudomi, T., Yamamoto, N., Asakawa, T., Yoshimoto, T., Takata, S., Tamura, T.

“…Mature progression-free survival (PFS) data from the phase III J-ALEX study showed superiority for alectinib versus crizotinib [hazard ratio (HR) 0.37, 95%…”
Get full text

IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel in 1L advanced squamous NSCLC by Socinski, M.A., Rittmeyer, A., Shapovalov, D., Orlandi, F., McCleod, M., Soo, R.A., Palmero, R., Kozuki, T., Migliorino, M.R., Koynov, K.D., Berard, H., Hughes, B.G.M., Yu, W., Graupner, V., Sun, S.W., Kowanetz, M., Hoang, T., Lin, W., Jotte, R.M.

Get full text

DNA topoisomerase II enzymes as molecular targets for cancer chemotherapy by Chikamori, K, Grozav, A G, Kozuki, T, Grabowski, D, Ganapathi, R, Ganapathi, M K

“…DNA topoisomerase II enzymes regulate essential cellular processes by altering the topology of chromosomal DNA. These enzymes function by creating transient…”
Get more information

A - 25 The Role of Prospective Memory in Instrumental Activities of Daily Living and the Use of Compensatory Aids in Mild Cognitive Impairment by Kozuki, Jordan T, Hickman, Angela, Sidhu, Jasman, Chapp, Andrew, Lent, David, Wright, Matthew, Schmitter-Edgecombe, Maureen, Woo, Ellen

“…Abstract Objective Prospective memory (PM), which involves remembering to execute a future action, is impacted by Alzheimer’s disease. This study examined the…”
Get full text

Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer by KATAYAMA, H, UEOKA, H, SHIMIZU, N, TAKEMOTO, M, HIRAKI, Y, KIURA, K, TABATA, M, KOZUKI, T, TANIMOTO, M, FUJIWARA, T, TANAKA, N, DATE, H, AOE, M

“…The objective of this study was to assess the feasibility and effectiveness of an induction chemoradiotherapy regimen followed by surgery in patients with…”
Get full text

Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens’ antibacterial susceptibility by Niki, Y, Matsumoto, T, Kohno, S, Aoki, N, Watanabe, A, Sato, J, Hattori, R, Terada, M, Koashi, N, Kozuki, T, Maruo, A, Morita, K, Ogasawara, K, Takahashi, Y, Watanabe, J, Sunakawa, K, Totsuka, K, Hanaki, H, Yagisawa, M, Takeuchi, K, Fujimura, S, Takeda, H, Ikeda, H, Sato, N, Niitsuma, K, Saito, M, Koshiba, S, Kaneko, M, Miki, M, Nakanowatari, S, Honda, Y, Chiba, J, Takahashi, H, Utagawa, M, Kondo, T, Kawana, A, Konosaki, H, Aoki, Y, Ueda, H, Sugiura, H, Ichioka, M, Goto, H, Kurai, D, Okazaki, M, Yoshida, K, Yoshida, T, Tanabe, Y, Kobayashi, S, Okada, M, Tsukada, H, Imai, Y, Honma, Y, Nishikawa, K, Yamamoto, T, Kawai, A, Kashiwabara, T, Takesue, Y, Wada, Y, Nakajima, K, Toda, H, Mitsuno, N, Sugimura, H, Yoshioka, S, Kurokawa, M, Munekawa, Y, Nakajima, H, Kubo, S, Ohta, Y, Mikasa, K, Maeda, K, Kasahara, K, Koizumi, A, Sano, R, Yagi, S, Takaya, M, Kurokawa, Y, Kusano, N, Mihara, E, Kuwabara, M, Fujiue, Y, Ishimaru, T, Matsubara, N, Kawasaki, Y, Tokuyasu, H, Masui, K, Negayama, K, Ueda, N, Ishimaru, M, Nakanishi, Y, Fujita, M, Honda, J, Kadota, J, Hiramatsu, K, Nagasawa, Z, Suga, M, Muranaka, H, Yanagihara, K, Fujita, J, Tateyama, M

“…Abstract For the purpose of a nationwide surveillance of the antimicrobial susceptibility of bacterial respiratory pathogens in patients in Japan, the Japanese…”
Get full text

The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility by Niki, Y, Hanaki, H, Yagisawa, M, Kohno, S, Aoki, N, Watanabe, A, Sato, J, Hattori, R, Koashi, N, Kozuki, T, Maruo, A, Morita, K, Ogasawara, K, Takahashi, Y, Watanabe, J, Totsuka, K, Takeuchi, K, Takahashi, M, Takeda, H, Ikeda, H, Kaneda, H, Niitsuma, K, Saito, M, Koshiba, S, Kaneko, M, Itabashi, S, Miki, M, Nakanowatari, S, Honda, Y, Chiba, J, Takahashi, H, Utagawa, M, Kondo, T, Kawana, A, Konosaki, H, Aoki, Y, Chonabayashi, N, Ueda, H, Sugiura, H, Ichioka, M, Goto, H, Aoshima, M, Okazaki, M, Ozawa, T, Horiuchi, F, Yoshida, T, Tsukada, H, Kobayashi, S, Yoshikawa, H, Imai, Y, Honma, Y, Yoshida, K, Takaya, M, Kurokawa, Y, Kuwabara, M, Fujiue, Y, Ishimaru, T, Matsubara, N, Kawasaki, Y, Tokuyasu, H, Masui, K, Shimizu, E, Yoneda, K, Negayama, K, Ueda, N, Ishimaru, M, Nakanishi, Y, Fujita, M, Honda, J, Kadota, J, Hiramatsu, K, Nagasawa, Z, Suga, M, Muranaka, H, Yanagihara, K, Fujita, J, Tateyama, M

“…Abstract The Japanese Society of Chemotherapy (JSC) conducted the first nationwide surveillance of bacterial respiratory pathogens during the period from…”
Get full text

Differences in p53 and cadherin-catenin complex expression between histological subtypes in diffusely infiltrating gastric carcinoma by Kozuki, T, Yao, T, Nakamura, S, Matsumoto, T, Tsuneyoshi, M

“…Aims:  The aim of this study was to elucidate possible clinicopathological differences between diffusely infiltrating gastric carcinoma of ‘pure type’ (poorly…”
Get full text

1052P Phase-Ib trial of metformin combined with nivolumab for refractory/recurrent solid tumors by Kubo, T., Kato, H., Horiguchi, S., Ninomiya, T., Kozuki, T., Asagi, A., Takamoto, A., Umeda, Y., Kamikawa, K., Yoshida, M., Udono, U., Hotta, K., Maeda, Y., Kiura, K.

Get full text

390P Entrectinib in Japanese patients (pts) with locally advanced/metastatic ROS1 fusion-positive (fp) NSCLC and NTRK-fp solid tumours by Murakami, H., Ohe, Y., Hayashi, H., Esaki, T., Yamaguchi, T., Fukuhara, T., Daga, H., Tanaka, H., Kozuki, T., Osborne, S., Bordogna, W., Goto, K.

Get full text

LBA70 OSIRAM-1: A multicenter, open label, randomized phase II study of osimertinib plus ramucirumab versus osimertinib alone as initial chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer (TORG1833) by Nakahara, Y., Kato, T., Isomura, R., Misumi, T., Tamiya, M., Yoh, K., Furuya, N., Ono, A., Takiguchi, Y., Koyama, K., Ikeda, S., Watanabe, K., Tokito, T., Seki, N., Imai, H., Shukuya, T., Shibata, Y., Hosokawa, S., Kozuki, T., Okamoto, H.

Get full text

1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001 by Fujimoto, N., Kozuki, T., Aoe, K., Miyamoto, Y., Wada, S., Harada, D., Yoshida, M., Sakurai, J., Hotta, K.

Get full text

Retrospective comparative study of the efficacy and safety in docetaxel and ramucirumab combination chemotherapy with or without previous immune checkpoint inhibitor treatment by Harada, D., Takata, K., Mori, S., Kozuki, T., Takechi, Y., Moriki, S., Asakura, Y., Ono, T., Nogami, N.

Get full text

1566P - Retrospective comparative study of the efficacy and safety in docetaxel and ramucirumab combination chemotherapy with or without previous immune checkpoint inhibitor treatment by Harada, D., Takata, K., Mori, S., Kozuki, T., Takechi, Y., Moriki, S., Asakura, Y., Ono, T., Nogami, N.

“…Salvage chemotherapy after immune checkpoint inhibitor (ICI) treatment has been reported to increase the antitumor effect. There are also some reports that…”
Get full text

1566PRetrospective comparative study of the efficacy and safety in docetaxel and ramucirumab combination chemotherapy with or without previous immune checkpoint inhibitor treatment by Harada, D, Takata, K, Mori, S, Kozuki, T, Takechi, Y, Moriki, S, Asakura, Y, Ono, T, Nogami, N

“…Abstract Background Salvage chemotherapy after immune checkpoint inhibitor (ICI) treatment has been reported to increase the antitumor effect. There are also…”
Get full text

1519TiP Japanese Society of Medical Oncology/Health Authority of the Japanese Government Cooperative Virtual Educational Program for Improving the Clinical Annotation for Cancer Genomic Medicine by Amano, T., Sunami, K., Naito, Y., Ennishi, D., Imai, M., Kage, H., Kanai, M., Kenmotsu, H., Komine, K., Koyama, T., T., Maeda, Morita, S., Saigusa, Y., Sakai, D., Ichiro, K., Kozuki, T., Sakashita, H., Kohsaka, S., Tsuchihara, K., Yoshino, T.

Get full text

1402PDocetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer by Harada, D, Hata, A, Okuda, C, Kaji, R, Masuda, Y, Takechi, Y, Kozuki, T, Nogami, N, Katakami, N

Get full text

Randomized trial of prophylactic minocycline for erlotinib-associated skin rash in non-small cell lung cancer (PEARL trial) by Kusaka, K., Tamura, A., Kozuki, T., Koreeda, Y., Kita, T., Endo, T., Shibayama, T., Hatakeyama, N., Miura, M., Yamashita, N., Takenoyama, M.

Get full text

368P Real-world characteristics, treatment, and outcomes of stage III non-small cell lung cancer in Japan: SOLUTION study by Murakami, H., Tsuboi, M., Harada, H., Sobue, T., Kato, T., Atagi, S., Tokito, T., Mio, T., Oizumi, S., Kozuki, T., Sone, T., Seike, M., Ohashi, K., Jinushi, M., Horinouchi, H.

Get full text